ENSYSCE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
ENSYSCE BIOSCIENCES, INC. (ENSC) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price of $87.04 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $87.04.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $178.97.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $191.13.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price $191.13.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2026-06-30 | $87.04 10-Q · filed 2026-08-13 |
| 2026-03-31 | $178.97 10-Q · filed 2026-05-15 |
| 2025-12-31 | $191.13 10-K · filed 2026-03-30 |
| 2025-09-30 | $191.13 10-Q · filed 2025-11-14 |
| 2025-06-30 | $191.13 10-Q · filed 2025-08-13 |
| 2025-03-31 | $216.10 10-Q · filed 2025-05-13 |
| 2024-12-31 | $501.65 10-K · filed 2025-03-10 |
| 2024-09-30 | $33.15 10-Q · filed 2024-11-12 |
| 2024-06-30 | $33.15 10-Q · filed 2024-08-14 |
| 2024-03-31 | $33.15 10-Q · filed 2024-05-13 |
| 2023-12-31 | $33.15 10-K · filed 2024-03-15 |
| 2023-09-30 | $707.59 10-Q · filed 2023-11-09 |
| 2023-06-30 | $707.63 10-Q · filed 2023-08-11 |
| 2023-03-31 | $707.63 10-Q · filed 2023-05-15 |
| 2022-12-31 | $58.96 10-K · filed 2023-03-30 |
| 2022-09-30 | $59.13 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.90 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.40 10-K · filed 2022-03-31 |
| 2021-09-30 | $2.40 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.40 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |